Sarepta Therapeutics | DŁUG



Debt Zmiana Data
Acadia Pharmaceuticals USD 56.29M 56.29M 2025-06
Agios Pharmaceuticals USD 48.76M 48.76M 2025-06
Alnylam Pharmaceuticals USD 1.3B 271.5M 2025-06
Amgen USD 56.2B 1.18B 2025-06
Biogen USD 6.59B 296.8M 2025-06
BioMarin Pharmaceutical USD 603.87M 8.22M 2025-06
Daiichi Sankyo JPY 101.33B 97M 2025-03
Eli Lilly USD 39.9B 1.39B 2025-06
Gilead Sciences USD 24.95B 6M 2025-06
Incyte USD 42.41M 5.29M 2025-06
Insmed USD 564.1M 567.29M 2025-06
Ionis Pharmaceuticals USD 1.42B 169.27M 2025-06
Moderna USD 741M 4M 2025-06
Neurocrine Biosciences USD 439.1M 8.4M 2025-06
Pfizer USD 60.93B 1.18B 2025-06
PTC Therapeutics USD 286.01M 2.12B 2025-06
Regeneron Pharmaceuticals USD 2.71B 300K 2025-06
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 22.28B 1.24B 2025-06
Sarepta Therapeutics USD 1.35B 215.59M 2025-06
Tectonic Therapeutic USD 876K 115K 2024-12
Ultragenyx Pharmaceutical USD 36.3M 1.98M 2025-06
Vertex Pharmaceuticals USD 1.53B 121.7M 2025-06


Sarepta Therapeutics DŁUG - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.